M. Castanheira

发表

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

R. Humphries, J. Ambler, S. Mitchell, 2018, Journal of Clinical Microbiology.

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Diagnostic microbiology and infectious disease.

Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014

Ronald N. Jones, M. Castanheira, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups

Ronald N. Jones, M. Castanheira, K. Krause, 2013, Antimicrobial Agents and Chemotherapy.

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).

Ronald N. Jones, M. Castanheira, A. Gales, 2012, Diagnostic microbiology and infectious disease.

Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

Ronald N. Jones, Mariana Castanheira, M. Castanheira, 2008, Microbial drug resistance.

Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007

Ronald N. Jones, M. Castanheira, D. Mathai, 2010, Antimicrobial Agents and Chemotherapy.

Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Ronald N. Jones, M. Castanheira, M. Toleman, 2005, International journal of antimicrobial agents.

Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2016, Antimicrobial Agents and Chemotherapy.

Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, R. Cantón, 2019, Open forum infectious diseases.

First description of bla(CTX-M-14)- and bla(CTX-M-15)-producing Escherichia coli isolates in Brazil.

M. Castanheira, B. Guth, A. Pignatari, 2010, Microbial drug resistance.

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2010, International journal of antimicrobial agents.

Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014

Ronald N. Jones, M. Castanheira, D. Farrell, 2016, Antimicrobial Agents and Chemotherapy.

Characterization of global patterns and the genetics of fusidic acid resistance.

M. Castanheira, I. Chopra, D. Farrell, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.

Ronald N. Jones, M. Castanheira, H. Sader, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, International journal of antimicrobial agents.

Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008

Ronald N. Jones, M. Castanheira, J. Turnidge, 2010, Antimicrobial Agents and Chemotherapy.

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).

Ronald N. Jones, M. Castanheira, D. Farrell, 2010, The Journal of antimicrobial chemotherapy.

Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)

Ronald N. Jones, M. Castanheira, R. Mendes, 2013, Antimicrobial Agents and Chemotherapy.

Molecular typing of antimicrobial-resistant Shiga-toxin-producing Escherichia coli strains (STEC) in Brazil.

M. Castanheira, A. Pignatari, M. Cergole-Novella, 2011, Research in microbiology.

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

M. Castanheira, P. Rhomberg, M. Pfaller, 2021, Antimicrobial Agents and Chemotherapy.

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Christina A. Cuomo, Brendan R. Jackson, B. Jackson, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of Uncommon Clinically Important Yeasts and Moulds by the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) System in a Global Antifungal Surveillance Program

Ronald N. Jones, M. Castanheira, M. Pfaller, 2015 .

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.

M. Castanheira, P. Rhomberg, M. Pfaller, 2015, Diagnostic microbiology and infectious disease.

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2014, Mycopathologia.

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Ronald N. Jones, M. Castanheira, M. Pfaller, 2012, Mycopathologia.

Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis

M. Castanheira, S. S. Andrade, A. Gales, 2006, Journal of Clinical Microbiology.

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019)

M. Castanheira, P. Rhomberg, M. Pfaller, 2021, The Journal of Antibiotics.

Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.

M. Castanheira, M. Huband, M. Pfaller, 2021, Diagnostic microbiology and infectious disease.

In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.

M. Castanheira, M. Pfaller, S. Messer, 2020, Diagnostic microbiology and infectious disease.

Molecular Characterization of a β-Lactamase Gene, blaGIM-1, Encoding a New Subclass of Metallo-β-Lactamase

Ronald N. Jones, M. Castanheira, F. Schmidt, 2004, Antimicrobial Agents and Chemotherapy.

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.

M. Castanheira, D. Farrell, H. Sader, 2011, International journal of antimicrobial agents.

and Interpretive Criteria of Candida by Using CLSI Methods and Caspofungin among 4 , 290 Clinical Isolates To Predict Susceptibility and Resistance to Use of Anidulafungin as a Surrogate Marker

Ronald N. Jones, M. Castanheira, M. Pfaller, 2014 .

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

Ronald N. Jones, M. Castanheira, M. Pfaller, 2014, Journal of Clinical Microbiology.

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Ronald N. Jones, M. Castanheira, M. Pfaller, 2013, Journal of Clinical Microbiology.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

M. Ghannoum, M. Castanheira, S. Lockhart, 2012, Journal of Clinical Microbiology.

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Journal of Clinical Microbiology.

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Diagnostic microbiology and infectious disease.

Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011 .

In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).

Ronald N. Jones, M. Castanheira, D. Farrell, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isolation of Genetically Unrelated bla NDM-1-Positive Providencia rettgeri Strains in Israel

M. Castanheira, G. Rahav, E. Mendelson, 2013, Journal of Clinical Microbiology.

Expansion of Clonal Complex 258 KPC-2-Producing Klebsiella pneumoniae in Latin American Hospitals: Report of the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, L. Deshpande, 2012, Antimicrobial Agents and Chemotherapy.

Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific Nations.

M. Castanheira, R. Jones, J. Bell, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Dissemination of bla(IMP-1)-carrying integron In86 among Klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23.

M. Castanheira, A. Gales, E. M. Mamizuka, 2009, Diagnostic microbiology and infectious disease.

High Prevalence of CTX-M-Producing Isolates and Emergence of KPC-encoding Genes in the Western United States

M. Castanheira, L. Woosley, R. Jones, 2009 .

Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18)

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, Antimicrobial Agents and Chemotherapy.

Characterization of an Integron Carrying blaIMP-1 and a New Aminoglycoside Resistance Gene, aac(6′)-31, and Its Dissemination among Genetically Unrelated Clinical Isolates in a Brazilian Hospital

Ronald N. Jones, M. Castanheira, M. Toleman, 2007, Antimicrobial Agents and Chemotherapy.

Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America.

Ronald N. Jones, M. Castanheira, M. Brandileone, 2003, Microbial drug resistance.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.

M. Castanheira, R. Jones, A. Gales, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program

M. Castanheira, D. Shortridge, R. Mendes, 2022, Microbiology spectrum.

In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes

M. Castanheira, P. Rhomberg, R. Mendes, 2021, The Journal of antimicrobial chemotherapy.

Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens

M. Castanheira, D. Shortridge, S. Arends, 2021, Antimicrobial agents and chemotherapy.

In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa

M. Castanheira, M. Dudley, Dongxu Sun, 2021, Antimicrobial Agents and Chemotherapy.

Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019

M. Castanheira, H. Sader, R. Mendes, 2021, The Journal of antimicrobial chemotherapy.

Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019

M. Castanheira, M. Huband, Jennifer D. Thompson, 2021, Antimicrobial agents and chemotherapy.

Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against Pseudomonas aeruginosa from cystic fibrosis patients

M. Castanheira, H. Sader, Timothy B Doyle, 2021, JAC-antimicrobial resistance.

Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016–19)

M. Castanheira, M. Huband, D. Shortridge, 2021, JAC-antimicrobial resistance.

Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016–2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides

Ronald N. Jones, M. Castanheira, H. Sader, 2020, Antimicrobial Agents and Chemotherapy.

Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

M. Castanheira, P. Thuras, James R. Johnson, 2020, Antimicrobial Agents and Chemotherapy.

Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide

M. Castanheira, C. Carvalhaes, H. Sader, 2020, Antimicrobial Agents and Chemotherapy.

Updated Prevalence of mcr-Like Genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY Program and Characterization of mcr-1.11 Variant

M. Castanheira, L. Deshpande, Cory Hubler, 2019, Antimicrobial Agents and Chemotherapy.

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States

Ronald N. Jones, M. Castanheira, V. Cattoir, 2019, Open forum infectious diseases.

Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010–2016): concomitant analysis of oritavancin in vitro activity

M. Castanheira, H. Sader, R. Mendes, 2018, Journal of chemotherapy.

Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

M. Castanheira, M. Huband, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates

M. Castanheira, M. Pfaller, D. Shortridge, 2017, Antimicrobial Agents and Chemotherapy.

Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009

M. Castanheira, P. Thuras, James R. Johnson, 2017, Antimicrobial Agents and Chemotherapy.

Ceftaroline Activity Tested against Bacterial Isolates Causing Community-Acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients from United States Hospitals: 2012-2014.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2017, The Pediatric infectious disease journal.

In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018

M. Castanheira, M. Pfaller, D. Shortridge, 2019, Antimicrobial Agents and Chemotherapy.

First Descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Weinstein, M. Castanheira, 2009, Journal of Clinical Microbiology.

Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages.

Ronald N. Jones, M. Castanheira, A. Wanger, 2013, Microbial drug resistance.

Prevalence and Antimicrobial Susceptibility Profile of ESBL- and KPC-producing Enterobacteriaceae in the United States (2003 − 2008)

M. Castanheira, H. Sader, R. Jones, 2010 .

1305. Antimicrobial Activity of Ceftaroline and Comparator Agents against Ceftriaxone-Non-Susceptible Streptococcus pneumoniae from the United States (2008-2020)

M. Castanheira, C. Carvalhaes, H. Sader, 2021, Microbial drug resistance.

Case report of transient mcr-1-haboring Escherichia coli with concurrent Staphylococcus aureus bacteremia in Long Beach, California.

M. Castanheira, J. Le, L. Deshpande, 2017, Diagnostic microbiology and infectious disease.

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Ronald N. Jones, M. Castanheira, J. Turnidge, 2019, Open forum infectious diseases.

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST).

Ronald N. Jones, M. Castanheira, M. Pfaller, 2013, The Journal of antimicrobial chemotherapy.

Comparative activity of posaconazole and systemic azole agents against clinical isolates of filamentous fungi from a global surveillance programme

M. Castanheira, P. Rhomberg, M. Pfaller, 2021, JAC-antimicrobial resistance.

The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011–2012)

M. Castanheira, P. Thuras, James R. Johnson, 2017, Open forum infectious diseases.

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

M. Castanheira, K. Borroto-Esoda, P. Rhomberg, 2017, Antimicrobial Agents and Chemotherapy.

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, The Journal of antimicrobial chemotherapy.

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Diagnostic microbiology and infectious disease.

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species

M. Castanheira, M. Pfaller, D. Diekema, 2010, Journal of Clinical Microbiology.

Potency of Anidulafungin Compared to Nine Other Antifungal Agents Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008)

Ronald N. Jones, M. Castanheira, S. Messer, 2010, Journal of Clinical Microbiology.

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Antimicrobial Agents and Chemotherapy.

Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals.

M. Castanheira, H. Sader, R. Mendes, 2019, The Journal of antimicrobial chemotherapy.

Antimicrobial Susceptibility of Pseudomonas aeruginosa: Results from Four years (2012-2015) of the International Network for Optimal Resistance Monitoring (INFORM) Program in the United States

M. Castanheira, M. Huband, H. Sader, 2017 .

Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).

Ronald N. Jones, M. Castanheira, D. Farrell, 2015, Diagnostic microbiology and infectious disease.

Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013

Ronald N. Jones, M. Castanheira, D. Farrell, 2015, Antimicrobial Agents and Chemotherapy.

Emergence of the Extended-Spectrum β-Lactamase GES-1 in a Pseudomonas aeruginosa Strain from Brazil: Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, T. Walsh, 2004, Antimicrobial Agents and Chemotherapy.

Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018)

M. Castanheira, P. Rhomberg, M. Pfaller, 2020, Antimicrobial Agents and Chemotherapy.

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2016, The Journal of antimicrobial chemotherapy.

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

M. Castanheira, S. Lockhart, M. Pfaller, 2012, Journal of Clinical Microbiology.

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

M. Castanheira, M. Arendrup, P. White, 2022, The Journal of antimicrobial chemotherapy.

Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020)

M. Castanheira, P. Rhomberg, M. Pfaller, 2022, Journal of clinical microbiology.

Mutation-Driven β-Lactam Resistance Mechanisms among Contemporary Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates from U.S. Hospitals

Ronald N. Jones, M. Castanheira, D. Farrell, 2014, Antimicrobial Agents and Chemotherapy.

OprD loss and hyperexpression of AmpC

Ronald N. Jones, M. Castanheira, D. Farrell, 2014 .

Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020

M. Castanheira, D. Shortridge, C. Carvalhaes, 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Antimicrobial Agents and Chemotherapy.

Analysis of Candida auris fungemia at a single facility in Kenya.

M. Castanheira, M. Pfaller, G. Revathi, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, International journal of antimicrobial agents.

In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).

Ronald N. Jones, M. Castanheira, M. Huband, 2016, International journal of antimicrobial agents.

Carriage of methicillin-resistant Staphylococcus aureus in children in Brazil.

M. Castanheira, R. Mendes, A. Pignatari, 2007, Diagnostic microbiology and infectious disease.

Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections

M. Castanheira, P. Rhomberg, M. Pfaller, 2022, Medical mycology.

Regional data analysis of Candida non‐albicans strains collected in United States medical sites over a 6‐year period, 2006–2011

Ronald N. Jones, M. Castanheira, M. Pfaller, 2014, Mycoses.

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii

M. Castanheira, K. Kaye, M. Rybak, 2021, Antibiotics.

Antimicrobial activity of ceftolozane-tazobactam tested against gram-negative contemporary (2015-2017) isolates from hospitalized patients with pneumonia in US medical centers.

M. Castanheira, D. Shortridge, C. Carvalhaes, 2019, Diagnostic microbiology and infectious disease.

Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Pseudomonas aeruginosa Isolates from US Hospitals Stratified by Site of Infection: Results From the INFORM Surveillance Program, 2013–2015

M. Castanheira, M. Huband, H. Sader, 2016 .

In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014

Ronald N. Jones, M. Castanheira, M. Huband, 2016, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).

Ronald N. Jones, M. Castanheira, D. Farrell, 2014, The Journal of antimicrobial chemotherapy.

Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012

Ronald N. Jones, M. Castanheira, D. Farrell, 2013, Antimicrobial Agents and Chemotherapy.

Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks Mutations

M. Castanheira, M. Pfaller, D. Andes, 2012, Antimicrobial Agents and Chemotherapy.

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Journal of Clinical Microbiology.

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2014, Diagnostic microbiology and infectious disease.

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

M. Castanheira, B. Alexander, Melissa D. Johnson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.

Ronald N. Jones, M. Castanheira, D. Farrell, 2017, Journal of global antimicrobial resistance.

Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.

M. Castanheira, P. Thuras, James R. Johnson, 2021, The Journal of antimicrobial chemotherapy.

Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe

M. Castanheira, D. Shortridge, L. Deshpande, 2022, JAC-antimicrobial resistance.

Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.

Ronald N. Jones, M. Castanheira, R. Mendes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, The Journal of antimicrobial chemotherapy.

Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).

Ronald N. Jones, M. Castanheira, R. Flamm, 2016, Diagnostic microbiology and infectious disease.

Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.

Ronald N. Jones, M. Castanheira, A. Gales, 2016, Microbial drug resistance.

Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy.

M. Castanheira, G. Fadda, T. Spanu, 2009, Clinical Microbiology and Infection.

Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites.

M. Castanheira, S. Unal, L. Deshpande, 2008, Journal of medical microbiology.

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

M. Castanheira, P. Rhomberg, M. Pfaller, 2018, Antimicrobial Agents and Chemotherapy.

Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans

M. Castanheira, P. Rhomberg, M. Pfaller, 2017, Antimicrobial Agents and Chemotherapy.

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Ronald N. Jones, M. Castanheira, M. Pfaller, 2013, Antimicrobial Agents and Chemotherapy.

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Ronald N. Jones, M. Castanheira, M. Pfaller, 2013, Journal of Clinical Microbiology.

In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012

Ronald N. Jones, M. Castanheira, M. Pfaller, 2015, Mycoses.

Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2014, International journal of antimicrobial agents.

In Vitro Antifungal Susceptibility of Candida glabrata to Caspofungin and the Presence of FKS Mutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection

M. Castanheira, J. Guarro, C. Lass‐Flörl, 2014, Antimicrobial Agents and Chemotherapy.

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Diagnostic microbiology and infectious disease.

Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)

M. Castanheira, M. Huband, M. Pfaller, 2022, Antimicrobial agents and chemotherapy.

Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata

M. Castanheira, P. Rhomberg, M. Pfaller, 2022, Mycoses.

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Ronald N. Jones, M. Castanheira, J. Guarro, 2011, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Antimicrobial Agents and Chemotherapy.

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.

Ronald N. Jones, M. Castanheira, L. Deshpande, 2014, The Journal of antimicrobial chemotherapy.

Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018)

M. Castanheira, M. Pfaller, D. Shortridge, 2022, Infection and drug resistance.

Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019–2020)

M. Castanheira, C. Carvalhaes, H. Sader, 2022, European Journal of Clinical Microbiology & Infectious Diseases.

Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).

M. Castanheira, C. Carvalhaes, H. Sader, 2021, Diagnostic microbiology and infectious disease.

OP-JANM210254 2600..2605

M. Castanheira, D. Shortridge, C. Carvalhaes, 2021 .

Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility.

M. Castanheira, M. Pfaller, D. Shortridge, 2017, Microbial drug resistance.

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

M. Castanheira, M. Huband, R. Mendes, 2017, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).

Ronald N. Jones, M. Castanheira, H. Sader, 2017, Diagnostic microbiology and infectious disease.

Tigecycline Activity Tested against Carbapenem-Resistant Enterobacteriaceae from European Hospitals: Results from the SENTRY Program (2010-2013)

M. Castanheira, H. Sader, D. Farrell, 2014 .

WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant &bgr;-lactamases

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2017, The Journal of antimicrobial chemotherapy.

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).

Ronald N. Jones, M. Castanheira, D. Farrell, 2015, Diagnostic microbiology and infectious disease.

Prevalent against Isolates Producing the Most Ceftazidime-Avibactam Activity Tested Census Regions and among Enterobacteriaceae in the Nine U . S .-Lactamases

Ronald N. Jones, M. Castanheira, K. Krause, 2014 .

Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae.

Ronald N. Jones, M. Castanheira, H. Sader, 2010, Microbial drug resistance.

Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.

M. Castanheira, R. Mendes, L. Deshpande, 2019, Journal of global antimicrobial resistance.

First Report of Plasmid-Mediated qnrA1 in a Ciprofloxacin-Resistant Escherichia coli Strain in Latin America

M. Castanheira, A. Gales, A. Barth, 2007, Antimicrobial Agents and Chemotherapy.

First Report of Plasmid-Mediated qnrA1 in a Ciproﬂoxacin-Resistant Escherichia coli Strain in Latin America (cid:1)

M. Castanheira, A. Gales, A. Barth, 2007 .

-Lactamase Family β Divergent Member of the VIM Metallo- Kinetic Characterization of VIM-7, a

M. Castanheira, Ø. Samuelsen, J. Spencer, 2014 .

Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

Ronald N. Jones, M. Castanheira, D. Livermore, 2009, Diagnostic microbiology and infectious disease.

Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program.

M. Castanheira, H. Sader, E. Rodriguez-Noriega, 2009, Microbial drug resistance.

Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo-β-Lactamase Family

M. Castanheira, Ø. Samuelsen, J. Spencer, 2008, Antimicrobial Agents and Chemotherapy.

RmtD 16S RNA Methylase in Epidemiologically Unrelated SPM-1-Producing Pseudomonas aeruginosa Isolates from Brazil

Ronald N. Jones, M. Castanheira, T. Fritsche, 2008, Antimicrobial Agents and Chemotherapy.

IMP-15-Producing Pseudomonas aeruginosa Strain Isolated in a U.S. Medical Center: a Recent Arrival from Mexico

M. Castanheira, H. Sader, L. Deshpande, 2008, Antimicrobial Agents and Chemotherapy.

Kinetic Characterization of VIM-7, a Divergent Member of the VIM Metallo- (cid:2) -Lactamase Family (cid:1)

M. Castanheira, Ø. Samuelsen, J. Spencer, 2008 .

First Isolation of blaVIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, M. Toleman, 2004, Antimicrobial Agents and Chemotherapy.

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

M. Castanheira, M. Pfaller, D. Shortridge, 2017, Antimicrobial Agents and Chemotherapy.

Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata.

M. Castanheira, J. Guarro, Adela Martin-Vicente, 2016, International Journal of Antimicrobial Agents.

Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020)

M. Castanheira, M. Huband, D. Shortridge, 2022, European Journal of Clinical Microbiology & Infectious Diseases.

Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).

M. Castanheira, M. Pfaller, H. Sader, 2017, International journal of antimicrobial agents.

Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).

M. Castanheira, M. Pfaller, H. Sader, 2017, Journal of global antimicrobial resistance.

Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection

M. Castanheira, P. Bradford, P. Simner, 2021, JAC-antimicrobial resistance.

Advances in Antifungal Susceptibility Testing of Candida, 2010–2012

Ronald N. Jones, M. Castanheira, M. Pfaller, 2012, Current Fungal Infection Reports.

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2013, Journal of Clinical Microbiology.

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.

M. Castanheira, M. Pfaller, 2015, Medical mycology.

Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

Ronald N. Jones, M. Castanheira, S. Lockhart, 2012, Current Fungal Infection Reports.

Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals

M. Castanheira, H. Sader, R. Mendes, 2019, Antimicrobial Agents and Chemotherapy.

Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates

Ronald N. Jones, Helio S. Sader, Mariana Castanheira, 2016, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

M. Castanheira, M. Huband, M. Pfaller, 2019, Antimicrobial Agents and Chemotherapy.

Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.

M. Castanheira, P. Rhomberg, M. Pfaller, 2018, Diagnostic microbiology and infectious disease.

Activity of Isavuconazole and Comparator Mould-Active Triazoles Tested against Contemporary Invasive Mould Isolates

M. Castanheira, P. Rhomberg, M. Pfaller, 2016 .

Activity of Isavuconazole and Comparator Antifungals Tested against Contemporary (2012) Fungal Clinical Isolates Collected Worldwide

M. Castanheira, S. Messer, M. Pfaller, 2013 .

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Ronald N. Jones, M. Castanheira, M. Pfaller, 2012, Journal of Clinical Microbiology.

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2014, Mycopathologia.

Activity of a Novel Echinocandin Biafungin (CD101) Tested against Most Common Candida and Aspergillus Species, Including Echinocandin- and Azole-resistant Strains

M. Castanheira, S. Messer, M. Pfaller, 2014 .

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012)

Ronald N. Jones, M. Castanheira, M. Pfaller, 2015, The Journal of Antibiotics.

Antimicrobial Activity of Cefoperazone-Sulbactam Tested against Gram-Negative Organisms from Europe, Asia-Pacific, and Latin America.

M. Castanheira, C. Carvalhaes, H. Sader, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Candidemia surveillance in Iowa: emergence of echinocandin resistance.

M. Castanheira, M. Pfaller, D. Diekema, 2014, Diagnostic microbiology and infectious disease.

CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.

M. Castanheira, P. Rhomberg, M. Pfaller, 2017, International journal of antimicrobial agents.

Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations

M. Castanheira, 2018, Journal of Clinical Microbiology.

Fungemia Surveillance in Denmark Demonstrates Emergence of Candida non- albicans , Higher Antifungal Usage and 1 Resistance Rates When Compared to Other Nations

M. Castanheira, 2018 .

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

M. Castanheira, P. Rhomberg, S. Messer, 2015, Diagnostic microbiology and infectious disease.

Activity of a Long-Acting Echinocandin (CD101) and Comparator Antifungal Agents Tested Against Contemporary Worldwide Invasive Fungal Isolates

M. Castanheira, P. Rhomberg, M. Pfaller, 2016 .

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype

M. Castanheira, Leah N. Woosley, S. Arends, 2018, mSphere.

Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17)

M. Castanheira, H. Sader, R. Mendes, 2018, The Journal of antimicrobial chemotherapy.

Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4

Ronald N. Jones, M. Castanheira, S. Jenkins, 2016, Antimicrobial Agents and Chemotherapy.

Detection of Methyltransferases Conferring High-Level Resistance to Aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America

Ronald N. Jones, M. Castanheira, T. Fritsche, 2008, Antimicrobial Agents and Chemotherapy.

Ceftazidime-Avibactam Activity against a Challenge Set of Carbapenem-Resistant Enterobacterales: Ompk36 L3 Alterations and β-Lactamases with Ceftazidime Hydrolytic Activity Lead to Elevated MIC Values.

M. Castanheira, H. Sader, R. Mendes, 2020, International journal of antimicrobial agents.

Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, T. Fritsche, 2007, Antimicrobial Agents and Chemotherapy.

Molecular Characterization of Baseline Enterobacterales and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial

M. Castanheira, M. Motyl, Elizabeth G. Rhee, 2020, Antimicrobial Agents and Chemotherapy.

Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Testing Susceptible to Cefepime by Reference Methods

Ronald N. Jones, M. Castanheira, R. C. Picão, 2013, Journal of Clinical Microbiology.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016, Antimicrobial Agents and Chemotherapy.

Characterization of the Pharmacokinetics-Pharmacodynamics of Tazobactam in 1 Combination with Piperacillin in an In Vitro Infection Model 2

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016 .

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2013, Antimicrobial Agents and Chemotherapy.

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

Ronald N. Jones, M. Castanheira, R. Mendes, 2008, Antimicrobial Agents and Chemotherapy.

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

M. Castanheira, M. Rybak, Razieh Kebriaei, 2019, Antimicrobial Agents and Chemotherapy.

Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

M. Castanheira, P. Thuras, James R. Johnson, 2020, Antimicrobial Agents and Chemotherapy.

Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016

M. Castanheira, D. Shortridge, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals during 2016 to 2018

M. Castanheira, D. Shortridge, R. Mendes, 2019, Antimicrobial Agents and Chemotherapy.

Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette Chromosome mec Types

Ronald N. Jones, M. Castanheira, D. Farrell, 2012, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Ronald N. Jones, Mariana Castanheira, M. Castanheira, 2012, Antimicrobial Agents and Chemotherapy.

In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii

M. Castanheira, K. Kaye, M. Rybak, 2021, Antimicrobial agents and chemotherapy.

Selection of the appropriate avibactam concentration for use with ceftibuten in broth microdilution susceptibility testing.

M. Castanheira, H. Sader, L. Deshpande, 2022, Diagnostic microbiology and infectious disease.

In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.

M. Castanheira, K. Krause, R. Mendes, 2019, Diagnostic microbiology and infectious disease.

In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes

M. Castanheira, K. Krause, R. Mendes, 2018, Antimicrobial Agents and Chemotherapy.

Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).

Ronald N. Jones, M. Castanheira, D. Farrell, 2016, International journal of antimicrobial agents.

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

Ronald N. Jones, M. Castanheira, H. Seifert, 2019, Open forum infectious diseases.

Resistance surveillance program report for selected European nations (2011).

Ronald N. Jones, M. Castanheira, M. Flonta, 2014, Diagnostic microbiology and infectious disease.

Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.

M. Castanheira, C. Carvalhaes, H. Sader, 2020, The Journal of antimicrobial chemotherapy.

Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.

Ronald N. Jones, M. Castanheira, D. Farrell, 2012, Diagnostic microbiology and infectious disease.

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: a SENTRY Antimicrobial Surveillance Program report.

Ronald N. Jones, M. Castanheira, A. Gales, 2007, Microbial drug resistance.

In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae, Including Molecularly Characterized Strains

M. Castanheira, P. Rhomberg, T. Lister, 2020, Antimicrobial Agents and Chemotherapy.

1590. Activity of Meropenem-Vaborbactam and Single-Agent Comparators against Enterobacterales Isolates Including KPC-Producing Isolates, from European Patients Hospitalized with Pneumonia Including Ventilator-Associated Pneumonia (2014-2019)

M. Castanheira, L. Deshpande, J. Streit, 2020 .

1589. Activity of Meropenem-Vaborbactam and Comparators against Globally Disseminated Klebsiella pneumoniae Sequence Type 258

M. Castanheira, L. Deshpande, Timothy B Doyle, 2020, Open Forum Infectious Diseases.

Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets

Mariana Castanheira, M. Castanheira, P. Bradford, 2017, Antimicrobial Agents and Chemotherapy.

Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016).

H. Goossens, M. Castanheira, H. Sader, 2019, The Journal of antimicrobial chemotherapy.

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries

M. Castanheira, H. Sader, R. Mendes, 2018, The Journal of antimicrobial chemotherapy.

TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.

Ronald N. Jones, M. Castanheira, Gary J. Moet, 2009, The Journal of antimicrobial chemotherapy.

Characterization of Enterobacter cloacae and Citrobacter freundii species complex isolates with decreased susceptibility to cephalosporins from United States hospitals and activity of ceftazidime/avibactam and comparator agents

M. Castanheira, H. Sader, R. Mendes, 2021, JAC-antimicrobial resistance.

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

M. Kuskowski, M. Castanheira, James R. Johnson, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015

Ronald N. Jones, M. Castanheira, R. Mendes, 2016, Antimicrobial Agents and Chemotherapy.

Enhanced activity of cefepime-tazobactam (WCK 4282) against KPC-producing Enterobacteriaceae when tested in media supplemented with human serum or sodium chloride.

M. Castanheira, P. Rhomberg, H. Sader, 2017, Diagnostic microbiology and infectious disease.

Relationship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model

Ronald N. Jones, M. Castanheira, J. McCauley, 2014, Antimicrobial Agents and Chemotherapy.

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Ronald N. Jones, M. Castanheira, J. McCauley, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Ronald N. Jones, M. Castanheira, G. Drusano, 2011, Antimicrobial Agents and Chemotherapy.

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.

M. Castanheira, P. Bradford, R. Mendes, 2018, International journal of antimicrobial agents.

β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates

Ronald N. Jones, M. Castanheira, R. Mendes, 2015, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane-Tazobactam Susceptibility (PACTS) surveillanc

M. Castanheira, M. Pfaller, D. Shortridge, 2018, Diagnostic microbiology and infectious disease.

Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing Strains

Ronald N. Jones, M. Castanheira, H. Sader, 2015, Antimicrobial Agents and Chemotherapy.

Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.

M. Castanheira, D. Paterson, M. Bassetti, 2022, The Journal of antimicrobial chemotherapy.

Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates

M. Castanheira, H. Sader, R. Mendes, 2021, The Journal of antimicrobial chemotherapy.

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.

M. Castanheira, M. Huband, M. Pfaller, 2018, International journal of antimicrobial agents.

The application of in vitro surveillance data for antibacterial dose selection

Ronald N. Jones, M. Castanheira, H. Sader, 2017, Current opinion in pharmacology.

Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase 3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP).

M. Castanheira, M. Motyl, Elizabeth G. Rhee, 2021, International journal of antimicrobial agents.

Prevalence of carbapenemase genes among carbapenem-nonsusceptible Enterobacterales collected in US hospitals in a five-year period and activity of ceftazidime/avibactam and comparator agents

M. Castanheira, H. Sader, R. Mendes, 2022, JAC-antimicrobial resistance.

Activity of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem-Relebactam against Carbapenemase-negative Carbapenem-resistant Enterobacterales (CRE) isolates from US Hospitals.

M. Castanheira, H. Sader, R. Mendes, 2021, International journal of antimicrobial agents.

Activity of Ceftaroline-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Collected from USA Hospitals in 2011

M. Castanheira, H. Sader, R. Flamm, 2012 .

First reported human isolation of Staphylococcus delphini.

K. Carroll, M. Castanheira, L. Westblade, 2019, Diagnostic microbiology and infectious disease.

Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and Comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.

M. Castanheira, H. Sader, R. Mendes, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Prevalence and Genetic Characterization of bla CTX-M Among Klebsiella pneumoniae Isolates Collected in an Intensive Care Unit in Brazil

M. Castanheira, A. Gales, M. Tognim, 2008, Journal of chemotherapy.

Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009

A. Robicsek, M. Kuskowski, M. Castanheira, 2012, Emerging infectious diseases.

Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.

Ronald N. Jones, R. Lynfield, M. Castanheira, 2013, Diagnostic microbiology and infectious disease.

Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)

Ronald N. Jones, M. Castanheira, A. Gales, 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015).

M. Castanheira, M. Pfaller, D. Shortridge, 2017, Journal of global antimicrobial resistance.

OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum Cephalosporins

Ronald N. Jones, M. Castanheira, P. Nordmann, 2011, Antimicrobial Agents and Chemotherapy.

Activity of meropenem-vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators, and region.

M. Castanheira, P. Thuras, James R. Johnson, 2021, Journal of global antimicrobial resistance.

677. Activity of Novel β-Lactamase Inhibitor QPX7728 Combined with β-Lactam Agents When Tested Against Carbapenem-Resistant Enterobacteriaceae (CRE) Isolates

M. Castanheira, R. Mendes, H. Huynh, 2019, Open Forum Infectious Diseases.

Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).

M. Castanheira, M. Pfaller, D. Diekema, 2020, Diagnostic microbiology and infectious disease.

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)

M. Castanheira, R. Mendes, S. Arends, 2023, Antimicrobial agents and chemotherapy.

Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014–2015)

M. Castanheira, M. Pfaller, D. Shortridge, 2019, Journal of chemotherapy.

Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002-2017).

J. R. Johnson, M. Castanheira, P. Thuras, 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

M. Castanheira, P. Rhomberg, M. Pfaller, 2017, Antimicrobial Agents and Chemotherapy.

Regional Resistance Surveillance Program Results for 12 Asia-Pacific Nations (2011)

Ronald N. Jones, M. Castanheira, J. Turnidge, 2013, Antimicrobial Agents and Chemotherapy.

Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Ronald N. Jones, M. Castanheira, A. Gales, 2006, Microbial drug resistance.

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program

M. Castanheira, R. Mendes, R. Flamm, 2018, The Journal of antimicrobial chemotherapy.

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).

M. Castanheira, M. Pfaller, D. Shortridge, 2017, International journal of antimicrobial agents.

Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011).

Ronald N. Jones, M. Castanheira, Y. Ni, 2013, Diagnostic microbiology and infectious disease.

Regional Resistance Surveillance Program Results for

M. Castanheira, J. Turnidge, R. Mendes, 2013 .

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).

Ronald N. Jones, M. Castanheira, R. Mendes, 2011, The Journal of antimicrobial chemotherapy.

Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.

Ronald N. Jones, M. Castanheira, D. Farrell, 2015, Diagnostic microbiology and infectious disease.

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).

M. Castanheira, M. Pfaller, H. Sader, 2018, Diagnostic microbiology and infectious disease.

Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015

M. Castanheira, D. Shortridge, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)

M. Castanheira, C. Carvalhaes, H. Sader, 2021, Antimicrobial agents and chemotherapy.

1629. Vancomycin Resistance in Enterococcus faecium Clinical Isolates Responsible for Bloodstream Infections in US Hospitals Over Ten Years (2010-2019) and Activity of Oritavancin

M. Castanheira, C. Carvalhaes, H. Sader, 2020 .

United States resistance surveillance results for linezolid (LEADER Program for 2007).

Ronald N. Jones, M. Castanheira, R. Mendes, 2008, Diagnostic microbiology and infectious disease.

Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022).

M. Castanheira, C. Carvalhaes, H. Sader, 2023, Diagnostic microbiology and infectious disease.

Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms

M. Castanheira, K. Krause, R. Flamm, 2018, The Journal of antimicrobial chemotherapy.

Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying blaKPC Collected in U.S. Hospitals from 2012 to 2015

M. Castanheira, H. Sader, R. Mendes, 2016, Antimicrobial Agents and Chemotherapy.

Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel

Ronald N. Jones, M. Castanheira, H. Sader, 2014, Journal of chemotherapy.

Pre-clinical Evaluation of a Carbapenem/ß-Lactamase Inhibitor Combination (RPX2003/RPX7009) Tested Against Serine-carbapenemase-producing Pathogens

M. Castanheira, P. Rhomberg, H. Becker, 2012 .

Eight broad-spectrum β-lactam Agents Tested Against a Large Collection of KPC-producing Enterobacteriaceae: Evaluation of Current CLSI Breakpoints

M. Castanheira, R. Jones, L. Deshpande, 2011 .

Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations.

Ronald N. Jones, M. Castanheira, H. Sader, 2017, Diagnostic microbiology and infectious disease.

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

M. Castanheira, H. Sader, R. Mendes, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Telavancin Activity Against a Global Collection of Staphylococcus aureus Clinical Isolates (2013–2015)

M. Castanheira, D. Shortridge, R. Mendes, 2017 .

Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014

Ronald N. Jones, M. Castanheira, H. Sader, 2016, Antimicrobial Agents and Chemotherapy.

Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.

Ronald N. Jones, M. Castanheira, D. Farrell, 2015, International journal of antimicrobial agents.

Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States.

Ronald N. Jones, M. Castanheira, H. Sader, 2014, Microbial drug resistance.

Ceftaroline activity tested against viridans group streptococci from US hospitals.

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2016, Diagnostic microbiology and infectious disease.

Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination.

M. Castanheira, M. Huband, E. Munson, 2017, Diagnostic microbiology and infectious disease.

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

M. Castanheira, M. Huband, M. Pfaller, 2020 .

1686. Antimicrobial Activity of Aztreonam-avibactam, Ceftazidime-Avibactam, and Comparator Agents against Pseudomonas aeruginosa from Cystic Fibrosis Patients

M. Castanheira, D. Shortridge, H. Sader, 2017, Open Forum Infectious Diseases.

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

M. Castanheira, M. Pfaller, H. Sader, 2018, Diagnostic microbiology and infectious disease.

Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency.

Ronald N. Jones, M. Castanheira, D. Farrell, 2016, The Journal of antimicrobial chemotherapy.

Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011-13).

Ronald N. Jones, M. Castanheira, D. Farrell, 2016, The Journal of antimicrobial chemotherapy.

Analysis of Global Antifungal Surveillance Results Reveals Predominance of Erg11 Y132F Alteration among Azole-Resistant Candida parapsilosis and Candida tropicalis and Country-Specific Isolate Dissemination.

M. Castanheira, P. Rhomberg, M. Pfaller, 2019, International journal of antimicrobial agents.

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

M. Castanheira, P. Rhomberg, M. Pfaller, 2016, Diagnostic microbiology and infectious disease.

Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients

C. Wanner, M. Castanheira, B. Polsky, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).

Ronald N. Jones, M. Castanheira, D. Farrell, 2010, The Journal of infection.

Characterization of Antimicrobial Susceptibility Patterns Among Community-Acquired Isolates of ß-Haemolytic Streptococci in Latin America: Results of SENTRY Antimicrobial Surveillance Program.

M. Castanheira, R. Jones, 2003 .

Update on Daptomycin Activity and Spectrum when Tested against Gram-positive Strains Collected in European Medical Centers (2007-2008)

M. Castanheira, H. Sader, R. Jones, 2009 .

378. Candida auris Fungemia: Risk Factors and Outcome

M. Castanheira, M. Pfaller, G. Revathi, 2018, Open Forum Infectious Diseases.

Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018

M. Castanheira, D. Shortridge, C. Carvalhaes, 2020, Antimicrobial Agents and Chemotherapy.

Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex

M. Castanheira, A. Gales, R. Mendes, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

1272. Cefiderocol In Vitro Activity Against Molecularly Characterized Acinetobacter baumannii-calcoaceticus Complex and Pseudomonas aeruginosa Clinical Isolates Causing Infection in United States Hospitals (2020)

M. Castanheira, D. Shortridge, H. Sader, 2021, Open Forum Infectious Diseases.

Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, Antimicrobial Agents and Chemotherapy.

Clonal Dissemination of Klebsiella pneumoniae Carbapenemase KPC-3 in Long Beach, California

Ronald N. Jones, M. Castanheira, J. Le, 2009, Journal of Clinical Microbiology.

Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.

Ronald N. Jones, M. Castanheira, R. Mendes, 2011, The Journal of antimicrobial chemotherapy.

Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).

Ronald N. Jones, M. Castanheira, H. Sader, 2008, Diagnostic microbiology and infectious disease.

Bactericidal Activity of Ceftaroline Combined with NXL104 Against Critical Targeted Organisms Possessing Various Resistance Mechanisms

M. Castanheira, I. Critchley, Gregory C. Williams, 2009 .

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions

M. Castanheira, M. Pfaller, H. Sader, 2017, Microbial drug resistance.

Comparison of ceftazidime-avibactam and ceftolozane-tazobactam in vitro activities when tested against gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2017-2018).

M. Castanheira, C. Carvalhaes, H. Sader, 2019, Diagnostic microbiology and infectious disease.

First Report of blaVIM-4- and mcr-9-Coharboring Enterobacter Species Isolated from a Pediatric Patient

M. Castanheira, L. Westblade, S. Jenkins, 2019, mSphere.

CEM-101 Activity against Gram-Positive Organisms

Ronald N. Jones, M. Castanheira, L. Woosley, 2010, Antimicrobial Agents and Chemotherapy.

Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.

M. Castanheira, M. Huband, R. Mendes, 2020, Diagnostic microbiology and infectious disease.

CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.

Ronald N. Jones, M. Castanheira, D. Farrell, 2010, Diagnostic microbiology and infectious disease.

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15)

M. Castanheira, M. Bassetti, M. Pfaller, 2017, The Journal of antimicrobial chemotherapy.

Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method for this alteration.

M. Castanheira, C. Carvalhaes, Cory M. Hubler, 2023, Diagnostic microbiology and infectious disease.

Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection

Ronald N. Jones, M. Castanheira, D. Biedenbach, 2010, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility of Pseudomonas aeruginosa to Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Piperacillin-Tazobactam, and Meropenem Stratified by U.S. Census Divisions: Results from the 2017 INFORM Program

M. Castanheira, C. Carvalhaes, H. Sader, 2018, Antimicrobial Agents and Chemotherapy.

Retrospective Molecular Analysis of DIM-1 Metallo-β-Lactamase Discovered in Pseudomonas stutzeri from India in 2000

Ronald N. Jones, M. Castanheira, Leah N. Woosley, 2013, Antimicrobial Agents and Chemotherapy.

Carbapenem-resistant Klebsiella pneumoniae Clinical Isolate Harbouring a blaIMP-4- and qnrS-carrying Plasmid, as well as a Conjugative blaKPC-2 Plasmid

M. Castanheira, Yang Xu, R. Mendes, 2014 .

Media for colistin susceptibility testing does not improve the detection of Klebsiella pneumoniae isolates carrying MgrB disruption and other mutation driven colistin resistance mechanisms.

M. Castanheira, P. Rhomberg, C. Carvalhaes, 2020, Diagnostic microbiology and infectious disease.

Evaluation of Clonality and Carbapenem Resistance Mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus Complex and Enterobacteriaceae Isolates Collected in European and Mediterranean Countries and Detection of Two Novel β-Lactamases, GES-22 and VIM-35

Ronald N. Jones, M. Castanheira, L. Deshpande, 2014, Antimicrobial Agents and Chemotherapy.

Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014–19)

M. Castanheira, D. Shortridge, C. Carvalhaes, 2021, The Journal of antimicrobial chemotherapy.

Analysis of Multidrug Resistance in Staphylococcus aureus with a Machine Learning-Generated Antibiogram

M. Castanheira, L. Westblade, Y. Gröhn, 2021, Antimicrobial Agents and Chemotherapy.

Emergence of a Plasmid Mediated blaVIM-1 in Citrobacter koseri: Report from the SENTRY Antimicrobial Surveillance Program (Italy)

M. Castanheira, A. Marchese, E. Debbia, 2009, Journal of chemotherapy.

IMP-33, a New IMP Variant Detected in Pseudomonas aeruginosa from Sicily

Ronald N. Jones, M. Castanheira, G. Blandino, 2013, Antimicrobial Agents and Chemotherapy.

Molecular and Biochemical Characterization of a Novel Class B ß-lactamase, GIM-1: a New Subclass of Metallo-ß-Lactamase: Report from the SENTRY Antimicrobial Surveillance Program

M. Castanheira, M. Toleman, R. Mendes, 2003 .

Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019–2021)

M. Castanheira, C. Carvalhaes, H. Sader, 2023, Open forum infectious diseases.

Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.

M. Castanheira, H. Sader, R. Flamm, 2018, Diagnostic microbiology and infectious disease.

Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019–21)

M. Castanheira, H. Sader, R. Mendes, 2023, JAC-antimicrobial resistance.

WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015

Ronald N. Jones, Helio S. Sader, Mariana Castanheira, 2017, Antimicrobial Agents and Chemotherapy.

Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates

M. Castanheira, D. Shortridge, Valerie Kantro, 2023, Microbiology spectrum.

In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program

M. Castanheira, M. Huband, S. Aronin, 2023, The Journal of antimicrobial chemotherapy.

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient

S. Richter, M. Castanheira, A. Mathers, 2018, Antimicrobial Agents and Chemotherapy.

Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016-2018.

M. Castanheira, C. Carvalhaes, H. Sader, 2020, Microbial drug resistance.

Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteria.

M. Castanheira, C. Carvalhaes, H. Sader, 2020, Diagnostic microbiology and infectious disease.

Trends of β-Lactamase Occurrence Among Escherichia coli and Klebsiella pneumoniae in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type

M. Castanheira, H. Sader, R. Mendes, 2023, Open forum infectious diseases.

Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010.

Ronald N. Jones, M. Castanheira, Sarah E. Farrell, 2013, Diagnostic microbiology and infectious disease.

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.

Ronald N. Jones, M. Castanheira, S. Shelburne, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2017, The Pediatric infectious disease journal.

Expanded Studies of CEM-101, a Novel Fluoroketolide, Tested against Invasive Isolates of Neisseria meningitidis, including Fluoroquinolone-non-susceptible Resistant Strains

M. Castanheira, L. Woosley, R. Jones, 2010 .

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

M. Castanheira, P. Rhomberg, M. Pfaller, 2023, Journal of Fungi.

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

M. Castanheira, P. Rhomberg, M. Pfaller, 2022, Journal of fungi.

Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015-2017).

M. Castanheira, H. Sader, R. Flamm, 2019, Diagnostic microbiology and infectious disease.

Performance of Fusidic Acid (CEM-102) Susceptibility Testing Reagents: Broth Microdilution, Disk Diffusion, and Etest Methods as Applied to Staphylococcus aureus

Ronald N. Jones, M. Castanheira, P. Rhomberg, 2010, Journal of Clinical Microbiology.

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Ronald N. Jones, M. Castanheira, M. Pfaller, 2012, Mycopathologia.

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

M. Castanheira, M. Huband, P. Rhomberg, 2023, Journal of fungi.

Murepavadin activity tested against contemporary (2016–17) clinical isolates of XDR Pseudomonas aeruginosa

Mariana Castanheira, M. Castanheira, G. Dale, 2018, The Journal of antimicrobial chemotherapy.

Fixed-Ratio Combination Testing of an Echinocandin, Anidulafungin, and an Azole, Voriconazole, against 1,467 Candida Species Isolates

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Antimicrobial Agents and Chemotherapy.

Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015–2019)

M. Castanheira, P. Rhomberg, C. Carvalhaes, 2022, The Pediatric infectious disease journal.

1236. Update on the In Vitro Activity of Ceftaroline against Staphylococcus aureus from United States (US) Medical Centers Stratified by Infection Type (2018-2020)

M. Castanheira, H. Sader, R. Mendes, 2021, Diagnostic microbiology and infectious disease.

Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activ

M. Castanheira, M. Pfaller, C. Carvalhaes, 2023, Mycoses.

Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles

M. Castanheira, M. Pfaller, L. Deshpande, 2021, Mycoses.

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

M. Castanheira, M. Pfaller, D. Shortridge, 2017, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

K-Mer Fingerprinting with RNN to predict MICs for K. pneumoniae

M. Castanheira, Cory Kromer-Edwards, Suely Oliveira, 2022, 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.

M. Castanheira, P. Rhomberg, M. Pfaller, 2021, Diagnostic microbiology and infectious disease.

Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015

M. Castanheira, H. Sader, R. Flamm, 2017, Antimicrobial Agents and Chemotherapy.

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)

M. Castanheira, R. Mendes, I. Critchley, 2023, Microbiology spectrum.

Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014–16)

M. Castanheira, M. Pfaller, H. Sader, 2018, The Journal of antimicrobial chemotherapy.

Antimicrobial Activity of First-in-Class Antifungal, Manogepix, and Comparator Agents Testing against Contemporary Invasive Fungal Isolates from an International Surveillance Program (2018-2019): In Vitro Activity of Manogepix against Fungal Isolates.

M. Castanheira, M. Huband, M. Pfaller, 2021, Journal of global antimicrobial resistance.

In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020)

M. Castanheira, R. Mendes, I. Critchley, 2022, Antimicrobial agents and chemotherapy.

Azole Resistance in Candida glabrata Clinical Isolates from Global Surveillance is Associated with Efflux Overexpression.

M. Castanheira, M. Pfaller, C. Carvalhaes, 2022, Journal of global antimicrobial resistance.

In Vitro Activity of Anidulafungin and Voriconazole and Comparators against Aspergillus spp. as Determined by CLSI and EUCAST Broth Microdilution Methods

M. Castanheira, S. Messer, M. Pfaller, 2011 .

The Plethora of Resistance Mechanisms in Pseudomonas aeruginosa: Transcriptome Analysis Reveals a Potential Role of Lipopolysaccharide Pathway Proteins to Novel β-lactam/β-lactamase Inhibitor Combinations.

M. Castanheira, R. Mendes, Timothy B Doyle, 2022, Journal of global antimicrobial resistance.

Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline

Samir N. Patel, Clinical, S. Richter, 2006 .

Using Feature Selection from XGBoost to Predict MIC Values with Neural Networks

M. Castanheira, Cory Kromer-Edwards, Suely Oliveira, 2023, 2023 International Joint Conference on Neural Networks (IJCNN).

Year, Location, and Species Information In Predicting MIC Values with Beta-Lactamase Genes

Suely Oliveira, Cory Kromer-Edwards, Mariana Castanheira, 2020, 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

155. In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Community-Acquired Pneumonia and Community-Acquired Lower Respiratory Tract Infections: Results from the SENTRY Antimicrobial Surveillance Program (2014-2020)

M. Castanheira, M. Huband, D. Shortridge, 2021, Open Forum Infectious Diseases.

Endemicity of Pseudomonas aeruginosa producing IMP-18 and/or VIM-2 MBLs from the high-risk clone ST111 in Central America

M. Castanheira, J. Tinoco, L. Deshpande, 2023, JAC-antimicrobial resistance.

Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination

M. Castanheira, M. Huband, H. Sader, 2023, Journal of clinical microbiology.

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

M. Castanheira, P. Rhomberg, M. Pfaller, 2023, Journal of fungi.

Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America

M. Castanheira, D. Shortridge, C. Carvalhaes, 2023, Microbiology spectrum.

Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.

Ronald N. Jones, L. Turner, M. Castanheira, 2012, Diagnostic microbiology and infectious disease.

1036. In Vitro Analysis of AmpC β-lactamase Induction by Tebipenem in Enterobacterales and Pseudomonas aeruginosa

M. Castanheira, R. Mendes, I. Critchley, 2021, Open Forum Infectious Diseases.

Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014

Ronald N. Jones, M. Castanheira, H. Sader, 2016, Antimicrobial Agents and Chemotherapy.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

M. Castanheira, C. Starling, J. Sifuentes-Osornio, 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Reply: regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

Ronald N. Jones, M. Castanheira, R. Mendes, 2014, Diagnostic microbiology and infectious disease.

Regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

Ronald N. Jones, M. Castanheira, R. Mendes, 2014, Diagnostic microbiology and infectious disease.

Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014.

Ronald N. Jones, M. Castanheira, M. Huband, 2016, Surgical infections.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, International journal of antimicrobial agents.

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

M. Castanheira, S. Lockhart, M. Pfaller, 2012, Journal of Clinical Microbiology.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2011, Diagnostic microbiology and infectious disease.

CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.

M. Castanheira, P. Rhomberg, M. Pfaller, 2017, International Journal of Antimicrobial Agents.

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

M. Castanheira, P. Rhomberg, M. Pfaller, 2018, Antimicrobial Agents and Chemotherapy.

Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility

M. Castanheira, S. Katiyar, T. Edlind, 2011, Antimicrobial Agents and Chemotherapy.

Ronald N. Jones, M. Castanheira, M. Pfaller, 2010, Journal of Clinical Microbiology.

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

Ronald N. Jones, M. Castanheira, R. Mendes, 2008, Antimicrobial Agents and Chemotherapy.

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

M. Castanheira, D. Greenberg, S. Atkin, 2018, Infection and drug resistance.

Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)

M. Castanheira, M. Huband, C. Carvalhaes, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017–2022)

M. Castanheira, M. Huband, C. Carvalhaes, 2024, Antimicrobial agents and chemotherapy.

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021

M. Castanheira, D. Shortridge, C. Carvalhaes, 2023, Microbiology spectrum.

Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.

Ronald N. Jones, M. Castanheira, R. Mendes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens from Japan (2006–2007)

Ronald N. Jones, M. Castanheira, K. Yanagihara, 2008 .